Cosentyx Sensoready is an autoinjector pen that delivers secukinumab, a monoclonal antibody that blocks interleukin-17A (IL-17A)—a protein involved in the body’s inflammatory response. This targeted action helps reduce the symptoms of chronic autoimmune diseases such as:

• Moderate to severe plaque psoriasis

• Psoriatic arthritis

• Ankylosing spondylitis

• Non-radiographic axial spondyloarthritis

• Hidradenitis suppurativa (in some cases)

The Sensoready Pen is designed for easy, once-monthly self-injection after initial weekly starter doses. Patients usually inject it into the thigh, abdomen, or upper arm, with minimal preparation required.

Benefits include:

• Clearer skin (in psoriasis)

• Reduced joint pain and stiffness (in arthritis)

• Convenient, at-home administration

Possible side effects include upper respiratory infections, headache, diarrhea, and increased risk of infections. It is not suitable for people with certain chronic infections or those with a compromised immune system without medical guidance.

Let me know if you want help with usage instructions or comparisons to other biologic pens like Humira or Enbrel.